Clinical Trial Update: Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating boosted Lexiva (fosamprenavir) with Lovaza adjunctive therapy in HIV-infected patients with hypertriglyceridemia. Results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hypertriglyceridemia

Drugs mentioned

• LOVAZA (OMEGA-3-ACID ETHYL ESTERS)
• Lexiva (Fosamprenavir)

Snippet

Sponsor: Felizarta, Franco, M.D. | Conditions: Hypertriglyceridemia, HIV Infection | Phase 4 | Status: COMPLETED | Results posted: 2012-04-18